PyInvesting

Market research

300813.SHE Zhejiang Tailin BioEngineering Co.,Ltd

SHE CNY Healthcare

Latest close

18.4 —

As of 30 Oct 2026

Test a moving-average rule with historical data.

Market facts
Market cap
2B
P/E ratio
97.2
Analyst target
Not available
Dividend yield
0.6%
Beta
1.21

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 6 months ago

Zhejiang Tailin BioEngineering Co.,Ltd is currently in a long term downtrend where the price is trading 13.2% below its 200 day moving average.

From a valuation standpoint, the stock is 6.9% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 10.3.

Based on the above factors, Zhejiang Tailin BioEngineering Co.,Ltd gets an overall score of 0/5.